These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1673583)

  • 1. Pharmacologic characterization of beta blockers with special reference to the significance of nonspecific membrane effects.
    Imai S
    Am J Cardiol; 1991 Apr; 67(10):8B-12B. PubMed ID: 1673583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of beta blockers: a class action or individual pharmacologic spectrum?
    Harrison DC
    Circulation; 1983 Jun; 67(6 Pt 2):I77-82. PubMed ID: 6133648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-Adrenergic Receptor Blockers in Hypertension: Alive and Well.
    Frishman WH
    Prog Cardiovasc Dis; 2016; 59(3):247-252. PubMed ID: 27984052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationships of antiarrhythmic drugs.
    Gupta SP
    Curr Pharm Des; 1998 Dec; 4(6):455-68. PubMed ID: 10197056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of membrane-stabilizing action in beneficial effect of beta adrenoceptor blocking agents on hypoxic and posthypoxic myocardium.
    Takeo S; Yamada H; Tanonaka K; Hayashi M; Sunagawa N
    J Pharmacol Exp Ther; 1990 Sep; 254(3):847-56. PubMed ID: 1975623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative properties of various beta-blockers, with an outlook to the future.
    van Zwieten PA
    Clin Physiol Biochem; 1990; 8 Suppl 2():18-27. PubMed ID: 1982758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.
    Hong CY; Turner P
    Br J Clin Pharmacol; 1982 Aug; 14(2):269-72. PubMed ID: 6125206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic properties and therapeutic use of beta adrenergic receptor blocking drugs].
    Shanks RG
    Medicina (B Aires); 1979; 39 Suppl 1():87-99. PubMed ID: 45034
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasoconstrictor-mediated increase in muscle resting thermogenesis is inhibited by membrane-stabilizing agents.
    Tong AC; Rattigan S; Dora KA; Clark MG
    Can J Physiol Pharmacol; 1997 Jul; 75(7):763-71. PubMed ID: 9315342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of beta-blockers: classical aspects and recent developments.
    Haeusler G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of beta-adrenergic blocking agents on specific binding of [3H]D-Ala2-Met5-enkephalinamide and [3H]naloxone.
    Takayama H; Ogawa N; Asanuma M; Hirata H; Ogura T; Ota Z
    Acta Med Okayama; 1991 Oct; 45(5):295-9. PubMed ID: 1684486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R; Brocks DR
    J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proxodolol--a new beta- and alpha-adrenoblockader].
    Iuzhakov SD; Dolgun OV; Dorodnikova EV; Aniukhovskiĭ EP; Baldenkov GN; Rozenshtraukh LV; Medvedev OS; Mashkovskiĭ MD
    Eksp Klin Farmakol; 1994; 57(3):30-3. PubMed ID: 7914115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.
    Singh BN
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S3-S14. PubMed ID: 15965570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of anti-arrhythmic beta-blockaders].
    Ito H; Goto K; Fuseno H; Hayase S
    Nihon Rinsho; 1974 Sep; 32(9):2859-64. PubMed ID: 4140928
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade.
    Frishman WH; Lazar EJ
    Am J Cardiol; 1990 Nov; 66(16):66G-70G. PubMed ID: 1978548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [General properties of beta-blockers].
    Godfraind T
    Rev Med Liege; 1981 Oct; 36 Suppl 1():5-13. PubMed ID: 6119758
    [No Abstract]   [Full Text] [Related]  

  • 19. Ganglionic effect of beta adrenergic receptor blocking agents.
    Minker E; Blazsó G; Köhegyi F
    Acta Physiol Acad Sci Hung; 1980; 55(1):63-70. PubMed ID: 6104891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of the thrombocytic effects of beta-adrenoblockaders].
    Tumasian KS; Akopov SE; Gabrielian ES
    Farmakol Toksikol; 1988; 51(5):49-53. PubMed ID: 2905276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.